Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
Severe acute respiratory syndrome coronavirus-2 (SAR-CoV-2) causes coronavirus disease 2019 (COVID19) that is responsible for short and long-term disease, as well as death, in susceptible hosts. The receptor binding domain (RBD) of the SARS-CoV-2 Spike (S) protein binds to cell surface angiotensin c...
Main Authors: | Ashlesha Deshpande, Bethany D. Harris, Luis Martinez-Sobrido, James J. Kobie, Mark R. Walter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.691715/full |
Similar Items
-
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
by: Min Jiang, et al.
Published: (2021-09-01) -
A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain
by: Ling Niu, et al.
Published: (2021-04-01) -
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
by: Rafael Bayarri-Olmos, et al.
Published: (2021-10-01) -
Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization
by: Bolshakova, T.N, et al.
Published: (2022) -
Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
by: Junping Hong, et al.
Published: (2021-07-01)